92.05
+1.15%
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Al Nahdi Medical Company SJSC
Its shares trade on Tadawul under the ticker 4164.SR. It has been listed since 22 March 2022. In the fiscal year to 31 December 2025, it reported revenue of SAR 10.21bn and net income of SAR 830.7m. At that date it held total assets of SAR 6.69bn and shareholders' equity of SAR 2.74bn.
Nahdi Medical Co. operates pharmacy stores. The company is headquartered in Jeddah, Makkah. The company went IPO on 2022-03-22. The firm is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods and medical equipment. The firm operates two operating segments: Front Shop and Pharma. The firm provides medicine, wellness, mom & baby, beauty and other wide-ranging FMCG products. The firm provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. The firm operates approximately 1,150 stores in 144 cities and towns in the Kingdom of Saudi Arabia and the United Arab Emirates. The Company’s subsidiaries include Al Nahdi Care, Sakhaa Golden Company, and Nahdi Investment Company.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 22 Mar 2022
- Employees
- 6,182
- Website
- nahdi.sa ↗
Leadership
Pay as last reported
- Mr. Saleh Salem Ahmed Bin MahfouzNon-Executive Chairman of the Board, since 2021SAR 500,000
- Eng. Yasser Ghulam Abdulaziz JoharjiChief Executive Officer, Executive Member of the Board, since 2014SAR 500,000
- Mr. Abdullah Amer Abdullah Al-NahdiNon-Executive Vice Chairman of the Board, since 2021SAR 500,000
- Mr. Mohammed Al-KhubaniChief Financial Officer
- Dr. Mohamed AbdulatifChief Operations Officer
- Mr. Samer BokhareeChief Human Resources Officer
- Dr. Hossam KhattabChief of Commercial and Marketing Officer
- Mr. Zuhair AytahChief Network Development Officer, since 2021
- Eng. Yassir JamalChief Supply Chain Officer
- Eng. Raed Jameel MonagelChief Corporate Governance and Business Support Officer
- Dr. Mohammed Mustafa SalimChief Omnihealth Officer
- Dr. Khalid TadlaouiChief Information Technology Officer, since 2021
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 19
- Environment
- 9
- Social
- 13
- Governance
- 35
- Women in the workforce
- 20%
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Operates 1,150 stores across 144 cities in Saudi Arabia and UAE
- Provides omni-health services including telemedicine and home healthcare
- Engaged in wholesale and retail trading of pharmaceuticals and cosmetics
Weaknesses
- Headquartered in Jeddah, Makkah with no mention of other locations
- Limited to operating in Saudi Arabia and UAE only
- Employees count of 6,182 may be insufficient for 1,150 stores
Opportunities
- Expanding into new markets beyond Saudi Arabia and UAE
- Growing demand for health and wellness products in Middle East
- Increasing adoption of telemedicine services in healthcare
Threats
- Competition from other pharmacy chains in Saudi Arabia
- Regulatory changes in pharmaceutical industry
- Economic downturn affecting consumer spending on non-essential items
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.